KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Interest Coverage Ratio (2017 - 2022)

Sarepta Therapeutics has reported Interest Coverage Ratio over the past 6 years, most recently at 15.97 for Q4 2022.

  • For Q4 2022, Interest Coverage Ratio fell 68.52% year-over-year to 15.97; the TTM value through Sep 2023 reached 59.7, down 476.85%, while the annual FY2023 figure was 12.17, 20.84% down from the prior year.
  • Interest Coverage Ratio for Q4 2022 was 15.97 at Sarepta Therapeutics, up from 20.78 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 1.67 in Q3 2021 and troughed at 444.11 in Q1 2019.
  • A 5-year average of 34.41 and a median of 10.34 in 2020 define the central range for Interest Coverage Ratio.
  • Biggest five-year swings in Interest Coverage Ratio: crashed 10929.44% in 2019 and later skyrocketed 98.05% in 2020.
  • Year by year, Interest Coverage Ratio stood at 19.23 in 2018, then crashed by 42.73% to 27.44 in 2019, then soared by 75.83% to 6.63 in 2020, then plummeted by 42.95% to 9.48 in 2021, then plummeted by 68.52% to 15.97 in 2022.
  • Business Quant data shows Interest Coverage Ratio for SRPT at 15.97 in Q4 2022, 20.78 in Q3 2022, and 12.45 in Q2 2022.